Selecta Biosciences Inc. (NASDAQ: SELB) stock fell -1.72% on Friday to $1.14 against a previous-day closing price of $1.16. With 0.71 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.96 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.1900 whereas the lowest price it dropped to was $1.1400. The 52-week range on SELB shows that it touched its highest point at $1.99 and its lowest point at $0.90 during that stretch. It currently has a 1-year price target of $3.50. Beta for the stock currently stands at 1.11.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Three-month performance dropped to -9.52% while six-month performance fell -19.72%. The stock lost -34.86% in the past year, while it has gained 0.88% so far this year. A look at the trailing 12-month EPS for SELB yields -0.23 with Next year EPS estimates of -0.18. For the next quarter, that number is -0.06. This implies an EPS growth rate of 207.90% for this year and 48.60% for next year.
Float and Shares Shorts:
At present, 153.44 million SELB shares are outstanding with a float of 114.98 million shares on hand for trading. On Aug 30, 2023, short shares totaled 9.81 million, which was 6.40% higher than short shares on Jul 30, 2023. In addition to Dr. Carsten Brunn Ph.D. as the firm’s CEO, Pres & Director, Mr. Blaine T. Davis serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 47.78% of SELB’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 32.20% of SELB, in contrast to 18.36% held by mutual funds. Shares owned by individuals account for 14.82%. As the largest shareholder in SELB with 5.96% of the stake, Invus Public Equities Advisors LL holds 9,136,635 shares worth 9,136,635. A second-largest stockholder of SELB, BlackRock Fund Advisors, holds 7,208,612 shares, controlling over 4.70% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in SELB, holding 6,968,127 shares or 4.54% stake. With a 2.48% stake in SELB, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 3,799,067 shares are owned by the mutual fund manager. The Fidelity Select Port. – Biotechno, which owns about 1.58% of SELB stock, is the second-largest Mutual Fund holder. It holds 2,421,075 shares valued at 2.98 million. iShares Russell 2000 ETF holds 1.56% of the stake in SELB, owning 2,392,150 shares worth 2.94 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, SELB reported revenue of $39.27M and operating income of $13.86M. The EBITDA in the recently reported quarter was $13.86M and diluted EPS was $0.06.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SELB since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SELB analysts setting a high price target of $5.00 and a low target of $1.00, the average target price over the next 12 months is $3.50. Based on these targets, SELB could surge 338.6% to reach the target high and fall by -12.28% to reach the target low. Reaching the average price target will result in a growth of 207.02% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded SELB stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 5 while that of sell transactions has risen to 22 over the past year. The total number of shares bought during that period was 693,738 while 218,496 shares were sold.
